Last update 01 Nov 2024
Jiangsu Hengyi Pharmaceutical Co., Ltd.

Jiangsu Hengyi Pharmaceutical Co., Ltd.

Private Company|
2009|
Jiangsu Sheng, China

Overview

Related

1
Drugs associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
(S)-Ornidazole Disodium Phosphate
Target
DNA
Mechanism
DNA modulators
Active Org.
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd.Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co.,Ltd. [+1]
Originator Org.
Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.Jiangsu Yangtze River Pharmaceutical Group Co., Ltd.
Active Indication
Bacterial Infections [+5]
Inactive Indication
Gingivitis [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date26 May 2021
1
Clinical Trials associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
CTR20161040 / CompletedPhase 1
中国健康受试者单/多次静脉注射磷酸左奥硝唑酯二钠的剂量递增的耐受性和药物代谢动力学研究
[Translation] Study on the tolerability and pharmacokinetics of single/multiple intravenous doses of levonidazole disodium phosphate in healthy Chinese subjects
100 Clinical Results associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Jiangsu Hengyi Pharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
(S)-Ornidazole Disodium Phosphate
 ( DNA )		Anaerobic bacterial infection
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free